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Background: Several delivery formats of cognitive behaviour therapy (CBT) for child anxiety have been proposed,
however, there is little consensus on the optimal delivery format. The primary goal of this study was to investigate the
impact of the child’s primary anxiety diagnosis on changes in clinical severity (of the primary problem) during
individual CBT, group CBT and guided parent-led CBT. The secondary goal was to investigate the impact of the
child’s primary anxiety diagnosis on rates of remission for the three treatment formats. Methods: A sample of 1,253
children (5–12 years; Mage = 9.3, SD = 1.7) was pooled from CBT trials carried out at 10 sites. Children had a
primary diagnosis of generalised anxiety disorder (GAD), social anxiety disorder (SoAD), specific phobia (SP) or
separation anxiety disorder (SAD). Children and parents completed a semistructured clinical interview to assess the
presence and severity of DSM-IV psychiatric disorders at preintervention, postintervention and follow-up. Linear
mixture modelling was used to evaluate the primary research question and logistic modelling was used to investigate
the secondary research question. Results: In children with primary GAD, SAD or SoAD, there were no significant
differences between delivery formats. However, children with primary SP showed significantly larger reductions in
clinical severity following individual CBT compared to group CBT and guided parent-led CBT. The results were
mirrored in the analysis of remission responses with the exception that individual CBT was no longer superior to
group CBT for children with a primary SP. The difference between individual and group was not significant when
follow-up data were examined separately. Conclusions: Data show there may be greater clinical benefit by allocating
children with a primary SP to individual CBT, although future research on cost-effectiveness is needed to determine
whether the additional clinical benefits justify the additional resources required. Keywords: Anxiety; treatment
trials; cognitive therapy.
Introduction
Up to 32% of children and adolescents attending
primary care settings present with a primary anxiety
disorder (Hansen, Oerbeck, Skirbekk, & Kristensen,
2016; Scott, Mughelli, & Deas, 2005). These prob-
lems are highly comorbid with one another (Rapee
et al., 2013), and children and adolescents with
these problems are at risk of suffering enduring
disability. Cognitive behaviour therapy (CBT) is
regarded as the front-line psychological treatment
for child anxiety with approximately 60% of children
in remission from their anxiety disorder diagnosis
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immediately after completing treatment (James,
James, Cowdrey, Soler, & Choke, 2015). However,
despite widespread support for CBT, the empirical
data clearly indicate that a sizeable proportion of
children do not recover. A clearer understanding of
the limits to CBT, and correspondingly, the ideal
conditions for delivery of CBT for child anxiety are
essential. There are now a variety of evidence-based
CBT programs defined under the broad term ‘CBT’.
Some of the main programs in the field are
trans-diagnostic, whereas other are disorder-specific
(Schneider et al., 2013), or intensive treatments
(Ollendick et al., 2009). Even though programs
share some important similarities, they also differ
in a number of areas; for example, duration, treat-
ment targets and level of parental involvement.
Efficacy of CBT treatment formats
Decisions regarding the best way to allocate children
to child anxiety treatments are currently poorly
understood. Our goal in the current study was to
investigate whether clinical responses to individual
CBT, group CBT and guided parent-led CBT are
influenced by the child’s primary anxiety diagnosis.1
There are very few published evaluations of the costs
of CBT treatments for child anxiety, but it is typically
presumed that whilst individual CBT allows for
extensive tailoring of treatments to the individual, it
is most expensive. Group CBT may be slightly
cheaper and there are invaluable opportunities for
peer normalisation, positive peer modelling, rein-
forcement and social support (Manassis et al.,
2002). Three trials have concluded that treatment
responses were no different for individual CBT and
group CBT (Liber et al., 2008; Manassis et al., 2002;
Wergeland et al., 2014). In contrast, one meta-
analysis showed that individual CBT for child anx-
iety led to superior effect sizes (on a child reported
self-report symptom measure) compared to group
CBT (Reynolds, Wilson, Austin, & Hooper, 2012).
Guided parent-led CBT (i.e. delivered directly to
children via their parents) can be delivered remotely
thereby increasing the chances that it is cost-
effective (Creswell et al., 2017; Lyneham & Rapee,
2006; Silverman, Pettit, & Lebowitz, 2016; Thirlwall
et al., 2013). A recent Cochrane review indicated
that there were no differences in the efficacy of
individual CBT, group CBT and family/parental
CBT2 (James et al., 2015).
Despite having important implications for clinical
decision making, previous meta-analyses (James
et al., 2015; Reynolds et al., 2012) are yet to eluci-
date if there is a clinical need to allocate children
presenting with a primary anxiety problem to a
particular treatment format. There are very plausible
reasons that there could be disorder-specific
responses to different treatment formats. For exam-
ple, in social anxiety disorder (SoAD) the group
situation may provide important opportunities for
practicing exposure skills, but it could also prove to
be too anxiety provoking, making it difficult for
children to engage with their therapist and learn
core CBT skills. It may be more difficult to deliver
group CBT to children with a specific phobia (SP) due
to the amount of psychoeducation and in-session
exposure typically needed to treat these cases. As
such, establishing whether individual CBT, group
CBT or guided parent-led CBT leads to similar
improvements for the range of child anxiety disor-
ders is an empirical question with important impli-
cations for the development of stepped care models.
Diagnosis and clinical responses to CBT treatment
formats
Three small RCTs (Liber et al., 2008; Manassis et al.,
2002; Wergeland et al., 2014) have investigated the
impact of having an SoAD diagnosis on clinical
outcomes following group or individual therapy.
Manassis et al. (2002) reported a significant inter-
action effect between type of anxiety disorder and
treatment approach in that children with high levels
of social anxiety symptoms improved significantly
more with individual CBT compared with group CBT.
A second trial showed no difference in outcomes for
children with a primary SoAD (Wergeland et al.,
2014). A third trial showed that when the child had
an SoAD diagnosis in their profile, greater reductions
in internalising symptoms (according to father’s
report) were achieved with group CBT compared to
those achieved by individual CBT (Liber et al., 2008).
These mixed findings are at odds with some findings
in the adult SoAD field that have shown individual
CBT is associated with more improvement in clinical
severity than group CBT (Ingul, Aune, & Nordahl,
2014; Stangier, Heidenreich, Peitz, Lauterbach, &
Clark, 2003). Taken together, these findings under-
score the need to investigate interactions between
treatment format and diagnosis in a large well-
powered sample.
The literature on the differential effect of individual
CBT and group CBT for response to different CBT
treatment formats in generalised anxiety disorder
(GAD), SP and separation anxiety disorder (SAD) is
sparse. Manassis et al. (2002) found greater reduc-
tions in mother-rated anxiety symptoms for children
with a primary GAD across both formats compared
with children with SAD, SoAD or SP. Another study
found that participants with a primary GAD diagno-
sis showed significantly greater reductions in par-
ent-rated anxiety and depressive symptoms in
individual CBT relative to group CBT, but children
with SAD benefitted equally (Wergeland et al. (2014).
The only trial that evaluated the impact of having a
primary SP on treatment responses found no differ-
ences between individual CBT and group CBT
(Manassis et al., 2002). Reasons contributing to the
variable pattern of results include the fact that
treatment responses were not always evaluated with
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
2 Anna McKinnon et al.
respect to changes in symptom severity and remis-
sion (Liber et al., 2008; Manassis et al., 2002). Some
studies assessed differences across primary prob-
lems (Wergeland et al., 2014), whereas others looked
at differences according to having a diagnosis in the
overall profile (Liber et al., 2008), some trials had
very small sample sizes that limited conclusions
(Liber et al., 2008; Manassis et al., 2002), and all
previous studies have used either a parent- or child-
rated self-report measure to measure symptom
change.
The present study investigated whether clinical
responses to treatment formats are influenced by the
child’s primary anxiety diagnosis. This will be the
first comparison of individual CBT, group CBT and
guided parent-led CBT within individual anxiety
disorder categories in the child anxiety field. We
used the Genes for Treatment dataset, which is a
pooled sample of children taking part in CBT treat-
ments for child anxiety (Hudson et al., 2015; Keers
et al., 2016). The dataset employed in this study was
significantly larger than previous RCT’s that have
assessed these questions in the field. The use of
pooled individual-level data in this study allows for
greater precision when controlling for covariates and
in the examination of potential treatment modera-
tors. This is also the first study to evaluate treatment
responses in a robust manner using a clinician-rated
composite measure derived from ratings on a struc-
tured clinical interview. Children were split into
diagnostic groups based on their primary anxiety
diagnosis. This is very relevant to both research and
routine clinical practice where it is commonplace for
the clinician to assess all presenting problems and
focus treatment on the disorder leading to the
highest levels of impairment.
The primary aim of this study was to investigate
the changes in clinical severity associated with
individual CBT, group CBT and parent-led CBT in
four separate primary anxiety disorder categories -
SoAD, GAD, SAD and SP. The secondary aim was to
assess these questions using rates of remission (i.e.
absence/presence of the primary diagnosis at the
end of treatment) as the core dependent variable of
interest. If significant relationships were found in the
main analyses, interactions between diagnosis and
treatment format would be explored. The current
state of the literature precluded any a priori hypothe-
ses regarding these interactions in the present
study.
Method
Sample
Data for 1,253 children3 aged between 5 and 12 years
(Mage = 9.3, SD = 1.7) was pooled from centres in Sydney,
Australia (n = 619; 49.40%) Reading, United Kingdom
(n = 299; 23.86%), Bergen, Norway (n = 84; 6.70%), Aarhus,
Denmark (n = 82; 6.54%), Bochum, Germany (n = 38; 3.03%),
Basel, Switzerland (n = 48; 3.83%), Miami, Florida (n = 40;
3.19%), Groningen, the Netherlands (n = 21; 1.68%), Oxford
(n = 20; 1.60%) and Amsterdam, the Netherlands (n = 2;
0.16%). The process of patient recruitment and the pooling of
data has been described in greater detail elsewhere (Hudson
et al., 2015; Lester et al., 2016; Roberts et al., 2015).
The inclusion criteria were: meeting DSM-IV criteria for a
primary diagnosis of GAD, SoAD, SP or SAD based on the
composite report of the parent and the child; having a sample
of DNA available for analysis, and taking part in a manualised
CBT treatment protocol. Exclusion criteria were a diagnosis of
significant intellectual impairment, a neurological disorder or
psychosis for the child.
Each study received ethical approval from their local hospi-
tal/university recruitment site. Informed consent was obtained
from adult carers/parents and assent from young people. The
demographic characteristics of the sample are presented in
Table 1. A description of the interventions carried out at the
different sites is reported elsewhere (Hudson et al., 2015) and
is summarized in Appendix S1.
Measures
The DSM-IV anxiety disorders were measured pre- and
postintervention via semistructured clinical interviews carried
out with parents and children. Across individual trials, follow-
up data were collected at variable time points (3, 6 or
12 months). All interviews were carried out by graduate level
staff or trainee psychologists.
The primary outcome, absolute change in clinical severity of
the child’s primary problem across treatment, was established
using clinician severity rating (CSR) scores on the Anxiety
Disorders Interview Schedule Child/Parent (ADIS-C/P; Silver-
man & Albano, 1996). In giving a CSR rating, the assessor
makes a single assessment of function on a scale from 0
(absent) to 8 (very severely disturbing/disabling) by consider-
ing the symptom severity, avoidance and interference with the
child’s functioning in core areas (e.g. school, family, friends,
peers). The secondary outcome, rates of remission (absence of
primary diagnosis) following treatment was determined
according to whether the child endorsed the requisite symp-
toms in line with the DSM criteria measured on the ADIS-C/P
(Silverman & Albano, 1996). A child’s diagnosis was assumed
to be in remission if he/she no longer presented with the
requisite symptoms required for the DSM diagnosis, which
corresponds to a CSR score of <4.
The vast majority of postassessments were blinded,
although for some trials and a minority of nontrial cases in
the sample this was not possible (see supplementary materials
in Appendix S1 for references to individual trials and a
description of methods). Inter-rater reliability was assessed
and found to be satisfactory (see supplementary details in
Appendix S1 for references to individual trials).
In Bochum, the diagnosis was made using the Diagnostis-
ches Interview bei psychischen Strungen im Kindes- und
Jugendalter (Kinder-DIPS; Neuschwander, In-Albon, Ador-
netto, Roth, & Schneider, 2013; Schneider, Unnewehr, &
Margraf, 2009). The Kinder-DIPS is based on the ADIS-C/P
and provides the same data as the ADIS.
Data analysis
All analyses were conducted in STATA Version 14 (StatCorp,
College Station, TX). As we were most interested in differences
in the efficacy of treatment formats within each disorder, linear
mixture models were carried out separately for each diagnostic
category. The primary dependent variable of interest was the
absolute change in clinical severity of the primary anxiety
problem. The secondary aim was to assess these questions
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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using rates of remission (i.e. absence/presence of the primary
diagnosis at the end of treatment) as the core-dependent
variable of interest. The main analysis was carried out using
outcome data pooled across post and follow-up time points (3,
6 or 12 months) as the dataset was underpowered to examine
fixed effects across time points due to the variable follow-up
time points (i.e. 3, 6 and 12 months) employed in individual
studies.
Absolute changes in clinical severity and remission rates
during the study period, and the extent of changes between
diagnostic categories for the Genes for Treatment sample, have
previously been reported (Hudson et al., 2015). A preliminary
analysis was carried out to show the results of this previous
study are replicated in this subsample of Genes for Treatment
dataset. A Linear Mixture Model was fitted using the linear and
quadratic effects of time, age, gender, baseline severity, treat-
ment format and diagnostic category as fixed effects and
clinical severity (i.e. CSR scores) as the dependant variable. In
a second similar set of analyses, a logistic regression model
was fitted with the same fixed effects and the dependent
variable was the presence/absence of the primary anxiety
disorder diagnosis.
For the main analyses investigating diagnosis-specific
effects, four separate Linear Mixture Models were carried out
to investigate the primary research questions regarding the
efficacy of treatment format within each diagnostic category
(GAD, SoAD, SP and SAD). All models included individual
random intercepts in order to account for the correlation of
repeated measures. Trials were nested within sites. Trial was
entered in the model as a higher order random effect to account
for possible differences by trial or site. The model included the
linear and quadratic effects of time, age, gender, baseline
severity, treatment format and diagnostic category as fixed
effects and CSR scores as the dependant variable of interest.
Supplementary analyses are also presented showing outcomes
for these analyses at post and follow-up time points. In a
second similar set of analyses, we used logistic regression
models to investigate remission of the primary diagnosis
following treatment in each of the four diagnostic categories.
Bonferroni corrections were employed and a p value of at
least .006 (.05/8) was set on each of the linear models to
indicate a significant result, based on eight analyses (four
linear regression models, four logistic regression models) being
conducted in the main analyses.
In addition to the separate analyses above for each diagno-
sis, we also conducted a formal test of the interaction between
diagnosis and treatment format on clinical severity with the
whole sample. Interactions were only investigated within a
diagnostic category if a significant result was found in the main
results. Given the exploratory nature of these analyses, a p
value of <.05 was set to indicate significance. To determine
whether there was an interaction of disorder and treatment
format on change in clinical severity and remission rates,
variables were dummy coded (SP vs. Other anxiety disorders,
individual CBT vs. Other CBT treatments) and then entered as
covariates in the model. Due to the nonrandomised nature of
the study, we also carried out a post-hoc logistic regression
analysis to see whether the proportions of children allocated to
treatment formats significantly differed within each diagnostic
category.
Results
Sample characteristics
Table 1 shows the baseline descriptive characteris-
tics across the four diagnostic categories. The major-
ity of the sample had a primary diagnosis of GAD
(n = 508), followed by SAD (n = 319), SoAD (n = 283)
and finally SP (n = 143). Across the samples, 9.4% of
children had a comorbid internalising disorder (a
nonanxiety internalising disorder) and 19.4% of
children had a comorbid externalising disorder.
The most common treatment format was group
CBT (52.0%; n = 652), followed by individual CBT
Table 1 Demographic and sample characteristics across diagnosis
GAD SoAD SP SAD Total Test statistic Differences
% of total
sample (N)
40.5 (507) 22.6 (283) 11.4 (143) 25.5 (319) 100 (1,253) v2 (3) = 216.63, p < .001 –
% Female
participants (n)
48.9 (248) 45.2 (128) 53.8 (77) 55.2 (176) 50.2 (629) H (3) = 7.04, p = .07 –
Age (M, SD) 9.4 (1.7) 9.5 (1.6) 9.4 (1.6) 9.0 (1.7) 9.3 (1.7) F (3) = 4.9, p = .002 GAD, SoAD,
SP > SAD
CSR severity at
baseline (M, SD)
6.2 (.94) 6.1 (1.0) 6.4 (1.1) 6.3 (1.0) 6.1 (1.0) F (3) = 2.4, p = .17 –
% Comorbid
externalising
disorder (n)
21.8 (107) 21.1 (53) 8.4 (19) 20.8 (47) 19.4 (226) H (3) = 7.04, p = .07 –
% Comorbid
internalising
disordera (n)
10.6 (52) 13.6 (34) 3.5 (5) 6.7 (19) 9.4 (110) H (3) = 14.1, p = .003 SoAD
> SP, SAD
% CBT treatment
(n)
Individual (n) 15.3 (78) 29.3 (83) 32.2 (46) 42.0 (134) 27.2 (341) H (3) = 73.6, p < .001 SoAD, SP, SAD
> GAD SAD
> SoAD, SP
Group (n) 65.7 (333) 50.2 (142) 41.3 (59) 37.0 (118) 52.1 (652) H (3) = 73.1, p < .001 GAD > SoAD,
SP, SAD
SoAD > SAD
Parent-led (n) 19.1 (97) 20.5 (58) 26.6 (38) 21.0 (67) 20.8 (260) H (3) = 14.1, p = .28 –
GAD, generalised anxiety disorder; SoAD, social anxiety disorder; SP, specific phobia; SAD, separation anxiety disorder; CSR,
Clinician severity rating score.
aComorbid internalising problem refers to a nonanxious internalising disorder.
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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(27.2%; n = 341) and then guided parent-led CBT
(20. 8%; n = 260). The proportion of cases at each
site within each treatment format for each primary
diagnostic category is reported in Table S1.
Average CSR severity scores ranged from 6.1
(SD = 1.0) to 6.4 (SD = 1.1) across categories. The
proportions of females in the four groups ranged
from 45.2% in primary SoAD to 55.2% in children
with primary SAD. The mean age of children across
diagnostic categories ranged from 9.0 years in the
SAD group to 9.5 years in the SoAD group. Of note,
children with primary SPs were the least likely to
have a comorbid nonanxiety internalising problem
(3.5%) and externalising problem (8.4%). In contrast,
rates of comorbid externalising problems were high-
est in the GAD group (21.8%) and rates of comorbid
nonanxiety internalising problems were highest in
the SoAD group (13.6%).
Changes in clinical severity and remission rates for
CBT treatment in the full sample
As reported previously (Hudson et al., 2015), there
was a significant reduction in clinical severity scores
(i.e. CSR scores; p < .001) during the study period
(Table S2). Children with a primary SoAD (p < .001)
diagnosis had significantly smaller reductions in
clinical severity during the study period relative to
GAD (p < .001), SP (p = .001), and SAD (p < .001).
Reductions in clinical severity were comparable for
GAD, SP and SAD (Table S2). Similarly, for the full
sample there were improvements in remission rates
(p < .001) during the study period (Table S2). Chil-
dren with a primary SoAD (p < .001) diagnosis were
also less likely to lose their diagnosis relative to GAD
(p < .001), SP (p = .003) and SAD (p < .001).
Improvements in remission rates were comparable
for GAD, SP and SAD.
Change in symptom level and remission rates for
CBT treatment formats across primary anxiety
disorder categories
Table 2 summarises the results of linear mixed
models evaluating changes in CSR scores over
treatment formats for the four diagnostic categories.
Treatment format did not have a significant effect on
changes in clinical severity for those with a primary
diagnosis of GAD, SoAD or SAD. These findings were
replicated in supplementary analyses carried out on
response data when postintervention (Tables S4a
and S4b) and follow-up (Tables S5a and S5b) data
were considered separately.
However, treatment format was significantly asso-
ciated with outcomes for children with SP. Individual
CBTwas associated with significantly larger improve-
ments in clinical severity than both group CBT
(p < .001) and guided parent-led CBT (p < .001).
Figure 1 shows the change in CSR scores for children
with a primary SP over the three assessment time
points in each of these treatment formats. These
results suggest a 1.58-point greater reduction in CSR
scores for individual CBT over group CBT and a 1.54-
point greater reduction in CSR scores for individual
CBT in comparison to guided parent-led CBT.
This result remained when outcomes were limited
to the post-treatment time point (Table S4a). At
follow-up, individual CBT was no longer more effec-
tive than guided parent-led CBT (p = .17) or group
CBT (p = .007) once Bonferroni corrections were
employed. This provides some evidence that the
significant advantage of individual CBT over both
Table 2 Results of linear mixed models examining the relationship between primary diagnosis and treatment format on changes in
clinical severity (CSR) using all follow-up points
GAD SoAD SP SAD
b (SE) 95% CI b (SE) 95% CI b (SE) 95% CI b (SE) 95% CI
Severity of
primary
diagnosis at
baselinea
.12* (0.03) [0.06, 0.19] .25* (0.04) [0.17, 0.33] .06 (0.06) [0.06, 0.18] .21* (0.05) [0.12, 0.30]
CBT treatment
Individual b b b b b b b b
Group-
basedc
.10 (0.16) [0.20, 0.41] .09 (0.16) [0.22, 0.41] .63* (0.15) [0.33, 0.93] .18 (0.16) [0.15, 0.50]
Guided
parent-ledc
.19 (0.18) [0.55, 0.17] .13 (0.20) [0.52, 0.27] .61* (0.17) [0.27, 0.95] .23 (0.21) [0.17, 0.64]
Age .01 (0.02) [0.04, 0.02] .00 (0.03) [0.05, 0.05] .05 (0.03) [0.03, 0.13] .00 (0.03) [0.05, 0.05]
Gender .13 (0.08) [0.02, 0.28] .13 (0.08) [0.02, 0.28] .02 (0.12) [0.26, 0.22] .12 (0.09) [0.05, 0.29]
GAD, generalised anxiety disorder; SoAD, social anxiety disorder; SP, specific phobia; SAD, separation anxiety disorder; CBT,
cognitive behaviour therapy.
aStandardised regression coefficients (b) significantly different than zero indicate association with clinical severity after treatment.
bReference category.
cStandardised regression coefficients (b) significantly different than zero indicate higher (negative value) or lower (positive value)
changes in clinical severity compared to the reference category.
*p < .006.
© 2018 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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treatments reduces at follow-up, although this find-
ing should be interpreted cautiously in light of the
smaller sample size at the follow-up analysis.
A similar pattern of results was observed in the
analysis of remission. Table 3 summarises the
results of logistic mixed models examining remission
rates over the three treatment formats within each
psychiatric condition. The mean severity sores of the
three treatment formats within each psychiatrist
condition are presented in Table S3. Treatment
format did not have a significant effect on improve-
ments in remission for GAD, SoAD and SAD. In
contrast, children with a primary SP who received
individual CBT were significantly more likely to lose
their SP diagnosis compared to children in guided
parent-led CBT (p = .005). There were no significant
differences in remission rates for individual CBT and
group CBT (p = .04) after correction for multiple
testing. This finding was replicated in the supple-
mentary analysis carried out on the postintervention
data (TableS4b). Therewereno significant differences
in remission rates between individual CBT, group
CBT and guided parent-led CBT for SP when the
follow-up data were analysed separately (Table S5b).
To determine whether there was a diagnosis (SP vs.
Other Anxiety Disorders) by treatment format (Indi-
vidual CBT vs. Other CBT treatments) interaction on
clinical severity, variables were dummy coded and
then entered as covariates in the regression model.
Preliminary analysis of baseline differences between
SP and Other Anxiety Disorders groups showed
there were no differences with respect to baseline
CSR scores, age, gender or presence of a comorbid
externalising problems (p > .05). Children in the SP
group were less likely than children in the other
categories to have a comorbid nonanxious internal-
ising problem (v2 (1) = 6.59 p = .01), however, this
variable was not controlled for in the analysis as a
high correlation of anxiety and mood problems in
youth is expected, and partialling out this variable
may remove an important element of the anxiety
construct of interest. The statistical interaction
between diagnosis (SP vs. Other Anxiety Disorders)
and treatment format (Individual CBT vs. Other CBT
treatments) on CSR scores was significant (p = .003;
based on a threshold of p < .05). Figure 2 sum-
marises this interaction. Individual CBT was more
effective than the other treatments for children with
primary SP (b = .63; CI95: [0.35, 0.89]; p < .001). In
contrast, individual CBT was no more effective than
other treatment formats for children with other
primary anxiety disorders (b = .04; CI95: [0.24,
0.16]; p = .71). Post-hoc analyses also suggested this
result was not an artefact of biases in treatment
allocation. Children with a primary SP were no more
likely to receive individual CBT compared to any
other sort of treatment (b = .33; CI95: [0.02, 0.68];
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Figure 1 Mean clinician severity rating (CSR) scores over time
across individual cognitive behaviour therapy (CBT), group CBT
and parent-led CBT for children with a primary specific phobia.
Post and follow-up means include covariates used in main
analysis
Table 3 Results of logistic mixed models examining the relationship between primary diagnosis and treatment format on change in
diagnostic frequency (remission) using all follow-up points
GAD SoAD SP SAD
OR (SE) 95% CI OR (SE) 95% CI OR (SE) 95% CI OR (SE) 95% CI
Severity of primary
diagnosis at
baselinea
0.75 (0.13) [0.52, 1.0] 0.45* (0.09) [0.30, 0.68] 0.70 (0.22) [0.38, 1.3] 0.35* (0.19) [0.21, 0.61]
CBT treatment
Individual b b b b b b b b
Group-basedc 0.75 (0.61) [0.15, 30.7] 0.64 (0.46) [0.16, 20.6] 0.15 (0.15) [0.02, 10.0] 0.47 (0.42) [0.08, 20.7]
Guided parent-ledc 10.4 (10.4) [0.20, 90.5] 0.70 (0.65) [0.11, 40.3] 0.05* (0.05) [0.01, 0.32] 0.08 (0.09) [0.01, 0.69]
Age 10.0 (0.09) [0.88, 10.2] 0.94 (0.11) [0.74, 10.2] 0.87 (0.16) [0.60, 10.3] 10.0 (0.15) [0.77, 10.4]
Gender 0.66 (0.19) [0.37, 10.2] 0.82 (0.29) [0.41, 10.6] 10.7 (0.97) [0.54, 50.2] 0.43 (0.20) [0.17, 10.1]
GAD, generalised anxiety disorder; SoAD, social anxiety disorder; SP, specific phobia; SAD, separation anxiety disorder; CBT,
cognitive behaviour therapy.
aOdds ratios of variables predicting a higher likelihood of remission are significantly greater than one, whereas variables predicting a
lower likelihood of remission have odds ratios of significantly <1.
bReference category.
cOdds ratios of variables predicting a higher likelihood of remission relative to the reference category are greater than one, whereas
variables predicting a lower likelihood of remission relative to the reference category have odds ratios of <1.
*p < .006.
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p = .07). The same pattern of significant and non-
significant comparisons was replicated when remis-
sion rates were investigated.
Discussion
In the present study, we evaluated the treatment
responses associated with individual CBT, group
CBT and guided parent-led CBT in a pooled sample
of children with a primary anxiety disorder diagno-
sis. Our results indicated there were no differences
across the three treatment formats for children with
primary SoAD, GAD or SAD. However, individual
CBT was better than guided parent-led CBT for SP in
terms of both improvement in symptoms and remis-
sion rates. Individual CBT also performed better
than group CBT for SP in the clinical severity change
analysis, but not in the remission analysis (after
correction for multiple testing). The interaction
between diagnosis (SP vs. Other anxiety disorders)
and treatment format (Individual CBT vs. Other CBT
treatments) on changes in clinical severity was
significant, with the analyses suggesting this was
not due to baseline severity of symptoms, site
differences, or biases in treatment allocation.
The inability to replicate the significant differences
between individual and group CBT for SP in the
remission model could be explained by the fact that
remission outcomes rely on cutoffs and are less well
powered. Our approach of applying Bonferroni cor-
rections to control for multiple comparisons may
have been overly restrictive. This finding is also at
odds with the Manassis et al. (2002) study, which
was limited by its small sample size. Whilst the
result found here was obtained in a large sample that
used a clinician-rated measure, it is also important
to acknowledge that our pooled analysis did not have
the same tight experimental controls as a single RCT.
In the present study, the statistics performed on the
primary outcome of interest are based on pooled
data from postintervention and follow-up measures
time points (3, 6 and 12 months), meaning that the
time point at which the significant effects took place
in this study is less clear than in the Manassis et al.
(2002) study. The difference between individual and
group for SP was observed when examining postdata
separately but not follow-up data. These differences
also offer potential explanations for the discrepant
results across the two studies.
Our results suggest that children with SPs can
improve in parent-led, group and individual CBT,
but they do significantly better in individual CBT. It
was particularly noteworthy that although SP tends
to be considered as less pervasive and more amen-
able to treatment, individual CBT produced better
outcomes than either group CBT or guided parent-
led approaches. Children present with a range of
SP’s in clinical settings. In individual CBT, thera-
pists tailor protocols by providing specific psychoe-
ducation surrounding the fear (e.g. education about
dog safety) as well as in-session-guided exposure to
feared situations, and training parents to be effica-
cious in guiding their child through the exposure
process. In group CBT and guided parent-led CBT,
such specificity to target avoidance behaviours may
not be possible, and this explanation may account
for the superiority of individual CBT here. The data
here show a stronger clinical benefit is associated
with the allocation of children with SPs to individual
CBT. However, decisions regarding the allocation of
children to a treatment format are complex, and
influenced by multiple factors including pragmatic
concerns (e.g. ability of parents to bring child to
appointments, demand for service, waiting lists etc.),
patient preferences and therapist preferences. Fur-
thermore, an analysis of the cost-effectiveness of
individual CBT for SP relative to the other treatment
formats is needed, given the additional resources
required per patient to deliver individual CBT.
These results are consistent with previous studies
showing individual CBT and group CBT are compa-
rable for GAD (Manassis et al., 2002), SoAD (Werge-
land et al., 2014) and SAD (Wergeland et al., 2014).
Our findings are at odds with other studies that
found outcomes with individual CBT to be better
than those with group CBT for children with GAD
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Figure 2 Mean clinician severity rating (CSR) scores over time for individual cognitive behaviour therapy relative to other treatments for
children with a primary specific phobia relative to children with other primary disorders. Post and follow-up means include covariates
from main analysis
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(Wergeland et al., 2014) and with SoAD (Liber et al.,
2008; Manassis et al., 2002). There could be numer-
ous reasons for this, including differences in sample
size, study design (outlined previously) and differ-
ences in the measures used to index dependant
variables of interest. The finding that children with
primary SoAD, GAD and SAD respond similarly,
regardless of treatment format implies that cheaper
treatments can be considered as a first line approach
for these disorders.
Some aspects of the present methodology merit
comment. Firstly, this sample was part of the Genes
for Treatment study and children could only be
included in the sample if they gave a saliva sample.
As such, there may be distinct differences in the
characteristics of children whose parents have con-
sented to provide a sample of their child’s saliva for
research purposes. Second, the majority of programs
included in this analysis were also trans-diagnostic
in nature. It is unclear whether the same pattern of
findings would be obtained if disorder-specific pro-
tocols were tested in samples of children with
heterogeneous psychiatric presentations. Third,
online self-help programs are now a very common
low intensity self-help approach, but these partici-
pants were excluded due to their low frequency in the
sample. A future study comparing ‘Internet delivery
to the three treatment formats examined in this
study is needed to give a definitive answer regarding
the utility of low intensity approaches. There are also
some statistical considerations worth noting. Group
sizes were uneven, with the fewest number of cases
found in the SP group (N = 158 cases) and a larger
group may have produced a different pattern of
results. While SP participants came from eight sites,
not all sites performed all protocols, so there might
still be a lingering effect of site, despite controlling for
this statistically. The results of the logistic regres-
sions carried out on follow-up data must be inter-
preted cautiously as the wide confidence intervals on
a number of results indicated the analysis was
underpowered. Finally, the analysis of follow-up
data separately from post-treatment data was under-
powered in this study.
There are some important avenues for future
research. An important next step will be to compare
the efficacy of individual CBT with the widely used
one-session CBT treatments for phobic youth (Ollen-
dick et al., 2009). As our pooling approach affords
less experimental control than can be gleaned from a
single RCT, there is a need for large-scale ran-
domised controlled trials with long-term follow-up
periods addressing differences in treatment format.
These studies should also measure important cog-
nitive and biological processes that could be driving
differential responses to CBT treatment formats.
Finally, a study to assess these questions among
adolescents is needed.
This is the first study to compare outcomes from
guided parent-led CBT, group CBT and individual
CBT among children with four primary anxiety
disorder diagnoses. Individual CBT was superior to
group CBT and guided parent-led CBT for children
with a primary SP. With variable CBT programs
being delivered in the community, further research
is needed to understand the optimal conditions
for allocating anxious children to different forms of
CBT.
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Key points
• The impact of CBT treatment format on response to treatment was investigated in a sample of children with a
primary GAD, SAD, SP and SoAD.
• In children with a primary GAD, SAD or SoAD, there were no differences between individual CBT, group CBT
and guided parent-led CBT.
• In children with a primary SP, individual CBT led to greater reductions in clinical severity and higher remission
rates than guided parent-led CBT.
• In children with a primary SP, individual CBT led to greater reductions in the clinical severity of primary
problems than group CBT.
• Allocation of children with SPs to individual CBT may have a stronger clinical benefit than allocation to group
or guided parent-led CBT.
• For children with GAD, SoAD and SAD decisions about treatment format can incorporate cost considerations
and patient choice.
Notes
1. Theprimary problem is the disorder deemedby the
clinician to be the most impairing of all the child’s
psychiatric diagnoses. This judgement is made by
consideration of symptom severity, avoidance, and
interference with core aspects of functioning for each
psychiatric diagnosis.
2. In this study, ‘family/parental CBT’ was defined
as treatment with the direct involvement of parents.
In some instances, the whole family was involved, in
others the parents were present for conjoint or
separate sessions, and sometimes the parents were
cotherapists.
3. Please note, whilst there were some cases taking
part in computer/internet CBT and some children
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with additional primary disorders (e.g. obsessive
compulsive disorder, posttraumatic stress disorder,
etc.) within the Genes for Treatment dataset, these
occurred with low frequency in the dataset and were
hence excluded from the analysis. Additionally, all
adolescents were excluded from the dataset as there
were no adolescents that took part in parent-led
CBT.
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